Found: 15
Select item for more details and to access through your institution.
The changing incidence of primary central nervous system lymphoma is driven primarily by the changing incidence in young and middle-aged men and differs from time trends in systemic diffuse large B-cell non-Hodgkin's lymphoma.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 12, p. 997, doi. 10.1002/ajh.23551
- By:
- Publication type:
- Article
Molecular Subtypes of Glioblastoma Are Relevant to Lower Grade Glioma.
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0091216
- By:
- Publication type:
- Article
The Role of Factor Inhibiting HIF (FIH-1) in Inhibiting HIF-1 Transcriptional Activity in Glioblastoma Multiforme.
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0086102
- By:
- Publication type:
- Article
Immunomodulatory treatment trial for paraneoplastic neurological disorders.
- Published in:
- Neuro-Oncology, 2004, v. 6, n. 1, p. 55, doi. 10.1215/S1152851703000395
- By:
- Publication type:
- Article
Primary central nervous system lymphoma can be histologically diagnosed after previous corticosteroid use: A pilot study to determine whether corticosteroids prevent the diagnosis of primary central nervous system lymphoma.
- Published in:
- Annals of Neurology, 2008, v. 63, n. 5, p. 662, doi. 10.1002/ana.21366
- By:
- Publication type:
- Article
International study on low‐grade primary central nervous system lymphomaMembers of the IPCG are listed in the Appendix on page 761.
- Published in:
- Annals of Neurology, 2006, v. 59, n. 5, p. 755, doi. 10.1002/ana.20804
- By:
- Publication type:
- Article
Delivery of chemotherapy and antibodies across the blood–brain barrier and the role of chemoprotection, in primary and metastatic brain tumors: report of the eleventh annual blood–brain barrier consortium meeting.
- Published in:
- Journal of Neuro-Oncology, 2007, v. 81, n. 1, p. 81
- By:
- Publication type:
- Article
Second malignancies in patients with primary central nervous system lymphoma.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 1, p. 129, doi. 10.1093/neuonc/nou105
- By:
- Publication type:
- Article
GENOME-WIDE ANALYSIS UNCOVERS RECURRENT ALTERATIONS IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMAS (PCNSL).
- Published in:
- Neuro-Oncology, 2014, v. 16, n. suppl_3, p. iii43, doi. 10.1093/neuonc/nou209.7
- By:
- Publication type:
- Article
Early measures of cognitive function predict survival in patients with newly diagnosed glioblastoma.
- Published in:
- Neuro-Oncology, 2012, v. 14, n. 6, p. 808, doi. 10.1093/neuonc/nos082
- By:
- Publication type:
- Article
Systemic immune suppression in glioblastoma: the interplay between CD14+HLA-DRlo/neg monocytes, tumor factors, and dexamethasone.
- Published in:
- Neuro-Oncology, 2010, v. 12, n. 7, p. 631, doi. 10.1093/neuonc/noq001
- By:
- Publication type:
- Article
Racial differences in primary central nervous system lymphoma incidence and survival rates.
- Published in:
- Neuro-Oncology, 2009, v. 11, n. 3, p. 318, doi. 10.1215/15228517-2008-103
- By:
- Publication type:
- Article
Histopathologic Grading of Adult Medulloblastomas.
- Published in:
- Cancer (0008543X), 2007, v. 109, n. 12, p. 2557, doi. 10.1002/cncr.22717
- By:
- Publication type:
- Article
High-dose intravenous methotrexate followed by autologous stem cell transplantation as a potentially effective therapy for neurolymphomatosis.
- Published in:
- Cancer (0008543X), 2004, v. 100, n. 11, p. 2403
- By:
- Publication type:
- Article
The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma.
- Published in:
- Cancer (0008543X), 2002, v. 95, n. 7, p. 1504, doi. 10.1002/cncr.10851
- By:
- Publication type:
- Article